[1] O’Donnell M J, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study[J]. Lancet,2010,376(9735):112-123.
[2] Egan B M, Zhao Y, Axon R N. US trends in prevalence, awareness, treatment, and control of hypertension [J]. JAMA,2010,303(20):2043-2050.
[3] 《中国高血压指南》修订委员会. 中国高血压防治指南2018年修订版[J]. 心脑血管病防治,2019,19(3):1-45.
[4] 胡大一,刘力生,余金明,等.中国门诊高血压患者治疗现状登记研究[J].中华高血压杂志,2010,29(6):600.
[5] 黄文蔚, 徐红新, 吕永楠, 等. 高血压合并多重心血管病危险因素的治疗现状及其影响[J].武汉大学学报(医学版), 2011,28(32):374-377.
[6] Wang W, Jiang B, Sun H, et al. Prevalence, Incidence, and Mortality of Stroke in China:Results from a Nationwide Population-Based Survey of 480 687 Adults[J]. Circulation,2017, 135: 759-771.
[7] 王 文, 王继光, 张宇清. 针对中国高血压的特点,制定中国高血压防治的策略与方案[J]. 中华高血压杂志,2010,18(9):904-907.
[8] Cooper-DeHoff R M, Gong Y, Handberg E M, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease [J]. JAMA,2010,304(1):61-68.